| CTP Marks 3-Year Anniversary With a Look Ahead Three years ago, Congress passed the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) and, in doing so, issued a challenge for the nation—to make tobacco-related disease and death a part of America’s past, not its future. Since then, the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products has moved science-based, tobacco-related regulation forward, including banning candy-like characterizing flavors; restricting youth access to cigarettes and smokeless tobacco; and prohibiting misleading advertising claims. CTP has begun a rigorous tobacco research program to enhance the knowledge already available to make evidence-based regulatory decisions and is working with its partners, including the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), to help identify the most effective means of answering regulatory science questions related to tobacco products. FDA has started a rigorous tobacco research program to enhance the knowledge already available to make evidence-based regulatory decisions. CTP’s priorities for research include: - Expanding understanding of the diversity of tobacco products;
- Reducing addiction to tobacco products;
- Reducing toxicity and carcinogenicity of tobacco products and smoke;
- Furthering understanding of the adverse health consequences of tobacco use;
- Broadening understanding of the communications about tobacco products; and
- Increasing knowledge about tobacco product marketing.
Learn more about CTP's accomplishments and goals for the future. | 
